Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial. (2020)
Attributed to:
A GMP cell therapy facility to test cell based therapies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-020-04416-w
PubMed Identifier: 32493473
Publication URI: http://europepmc.org/abstract/MED/32493473
Type: Journal Article/Review
Volume: 21
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215